- Mint Pharmaceuticals has expanded its distribution partnership with Bayer Canada to include Angeliq, Climara 25/50/75, Triquilar 21/28, And Xarelto granules for oral suspension in Canada.
- The collaboration builds on their existing distribution agreement for Adalat XL (nifedipine) and broadens the partnership across cardiovascular, women’s health, and other therapeutic areas.
- Mint will leverage its nationwide distribution network and supply-chain capabilities to support reliable supply and continuity of access to Bayer’s medicines for Canadian patients and healthcare professionals.
- The expanded partnership reinforces both companies’ focus on quality, supply continuity, and timely access to established medicines across Canada.
Takeaways:
Mint’s expanded partnership with Bayer strengthens its position as a Canadian pharmaceutical distribution partner, broadening its footprint across cardiovascular and women’s health. The agreement could improve supply continuity and market reach for Bayer’s established brands while reinforcing Mint’s competitive advantage through nationwide distribution capabilities.
Source: PRnewswire
